Five-Year Results of the Bioflow-III Registry: Real-World Experience with a Biodegradable Polymer Sirolimus-Eluting Stent-Reference-Cited by-同舟云学术

Five-Year Results of the Bioflow-III Registry: Real-World Experience with a Biodegradable Polymer Sirolimus-Eluting Stent

Published:2020-01 Issue:1 Volume:21 Page:63-69
ISSN:1553-8389
Container-title:Cardiovascular Revascularization Medicine
language:en
Short-container-title:Cardiovascular Revascularization Medicine

Author:

Waltenberger Johannes,Brachmann Johannes,van der Heyden Jan,Richardt Gert,Fröbert Ole,Seige Markus,Friedrich Guy,Erglis Andrejs,Winkens Mark,Hegeler-Molkewehrum Christian,Neef Martin,Hoffmann Stefan

Funder

BIOTRONIK AG

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference34 articles.

1. Abizaid A, Costa JR, Jr. New drug-eluting stents: an overview on biodegradable and polymer-free next-generation stent systems. Circ Cardiovasc Interv 2010;3:384–393.

2. Biodegradable coating for drug-eluting stents—more than a facelift?;Niemela;Eur Heart J,2008

3. State of the art: coronary artery stents - past, present and future;Stefanini;EuroIntervention,2017

4. Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trial;Windecker;Circ Cardiovasc Interv,2015

5. Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: 5-year outcomes of the randomized BIOFLOW-II trial;Lefèvre;JACC Cardiovasc Interv,2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Percutaneous Coronary Interventions with Sirolimus-Eluting Alex Plus Stents in Patients with or without Diabetes: 4-Year Results;Journal of Cardiovascular Development and Disease;2024-05-22

2. 24-Month Clinical Follow-Up and Mechanistic Insights From Intravascular Imaging Following Coronary Implantation of the Novel DynamX Bioadaptor Platform;Cardiovascular Revascularization Medicine;2023-01

3. Five-Year Clinical Outcome of the Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent Compared to the Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: From the SORT OUT VII Trial;Circulation: Cardiovascular Interventions;2023-01

4. Final 5‐Year Report of the Randomized BIO‐RESORT Trial Comparing 3 Contemporary Drug‐Eluting Stents in All‐Comers;Journal of the American Heart Association;2022-11-15

5. Clinical outcomes of an ultrathin-strut sirolimus-eluting stent in all-comers population: Thailand Orsiro registry;BMC Cardiovascular Disorders;2021-10-16